Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Kairos Pharma, Ltd. (AMEX:KAPA) with a Buy rating and announced a price target of $12. Kairos Pharma shares closed at $0.9185 on Wednesday. See how other analysts view this …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Kairos Pharma, Ltd. (AMEX:KAPA) with a Buy rating and announced a price target of $12. Kairos Pharma shares closed at $0.9185 on Wednesday. See how other analysts view this …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Joseph Pantginis initiated coverage on Kairos Pharma, Ltd. (AMEX:KAPA) with a Buy rating and announced a price target of $12. Kairos Pharma shares closed at $0.9185 on Wednesday. See how other analysts view this …Full story available on Benzinga.com Read MoreEQBK, KAPA, LFST, News, TALK, Top Initiations, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, TALK, EQBK, LFST, KAPA, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
